GenoDive Pharma Inc announced that it has received in an equity round of funding on May 31, 2024. The transaction included the participation from new investor I'rom Group Co., Ltd. The transaction has been approved by the extraordinary general meeting of shareholders and the company will issue the shares through third-party allotment method.